Evidence map›Paper›PMID 31781614›Full record

ArticleBioMed research international2019

Naringin Reverses High-Cholesterol Diet-Induced Vascular Dysfunction and Oxidative Stress in Rats via Regulating LOX-1 and NADPH Oxidase Subunit Expression.

Sirinat Pengnet, Sakdina Prommaouan, Phinsuda Sumarithum, Wachirawadee Malakul

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Resveratrol-like Compounds as SIRT1 Activators.International journal of molecular sciences · 2022
    Article
  14. Wax apple (Journal of traditional and complementary medicine · 2022
    Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Sirinat PengnetDepartment of Physiology, Faculty of Medical Science, Naresuan University, Phitsanulok 65000, Thailand.
Sakdina PrommaouanDepartment of Physiology, Faculty of Medical Science, Naresuan University, Phitsanulok 65000, Thailand.
Phinsuda SumarithumDepartment of Physiology, Faculty of Medical Science, Naresuan University, Phitsanulok 65000, Thailand.
Wachirawadee MalakulDepartment of Physiology, Faculty of Medical Science, Naresuan University, Phitsanulok 65000, Thailand.ORCID https://orcid.org/0000-0002-1677-2086
Naresuan University · THUniversity of Phayao · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypercholesterolaemia is associated with oxidative stress and endothelial dysfunction and leads to the development of atherosclerosis. Naringin exhibits cardiovascular protective and antioxidant properties. Therefore, the aim of this study was to assess the effect of naringin administration on vascular oxidative stress and endothelial dysfunction in hypercholesterolaemic rats and to elucidate its underlying mechanism. Sprague Dawley rats were fed a diet with 1.5% cholesterol (HCD) for 8 weeks to induce hypercholesterolaemia. Naringin (100 mg/kg body weight) was orally administrated to rats during the last 4 weeks of the diet treatment. After 8 weeks, the thoracic aorta was isolated to determine vascular function and nitric oxide (NO) levels. The aortic superoxide anion (O

Indexed as

AnimalsAortaAtherosclerosisCardiotonic AgentsDiet, High-FatDisease Models, AnimalEndothelial CellsFlavanonesGene Expression RegulationHumansHypercholesterolemiaNADPH Oxidase 2NADPH Oxidase 4NADPH OxidasesNitric OxideNitric Oxide Synthase Type IICardiotonic AgentsCybb protein, ratFlavanonesNADPH Oxidase 2NADPH Oxidase 4NADPH Oxidasesnaringinneutrophil cytosolic factor 1Nitric OxideNitric Oxide Synthase Type IINox4 protein, ratOLR1 protein, ratScavenger Receptors, Class E

Identifiers

PMID31781614
PMCPMC6855071
OpenAlexW2982257408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.